Home > National Drug Code (NDC) > Piperacillin and Tazobactam

Piperacillin and Tazobactam - 0409-3383-51 - (Piperacillin and Tazobactam)

Alphabetical Index


Drug Information of Piperacillin and Tazobactam

Product NDC: 0409-3383
Proprietary Name: Piperacillin and Tazobactam
Non Proprietary Name: Piperacillin and Tazobactam
Active Ingredient(s): 2; .25    g/10mL; g/10mL & nbsp;   Piperacillin and Tazobactam
Administration Route(s): INTRAVENOUS; PARENTERAL
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Piperacillin and Tazobactam

Product NDC: 0409-3383
Labeler Name: Hospira, Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA065362
Marketing Category: ANDA
Start Marketing Date: 20101021

Package Information of Piperacillin and Tazobactam

Package NDC: 0409-3383-51
Package Description: 10 VIAL, SINGLE-USE in 1 CARTON (0409-3383-51) > 10 mL in 1 VIAL, SINGLE-USE

NDC Information of Piperacillin and Tazobactam

NDC Code 0409-3383-51
Proprietary Name Piperacillin and Tazobactam
Package Description 10 VIAL, SINGLE-USE in 1 CARTON (0409-3383-51) > 10 mL in 1 VIAL, SINGLE-USE
Product NDC 0409-3383
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Piperacillin and Tazobactam
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS; PARENTERAL
Start Marketing Date 20101021
Marketing Category Name ANDA
Labeler Name Hospira, Inc
Substance Name PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Strength Number 2; .25
Strength Unit g/10mL; g/10mL
Pharmaceutical Classes beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA]

Complete Information of Piperacillin and Tazobactam


General Information